Key Findings:  CB2 activation may be a valuable and potential alternative treatment strategy to slow the progression and reduce the symptoms of cognitive decline in AD. CB2 receptors play an important role in the pathophysiology of PD and that their activation with selective agonist may lead to neuroprotective effect in the neurodegenerative processes of PD.
Type of Study:  Meta-analysis
Study Result:  Positive
Cannabinoids Studied:  Not Applicable
Phytocannabinoid Source:  Not Applicable